News - Page 662

TLDR: A lack of funding or investors is a major reason why startups fail, according to a survey of 500 founders. While venture capital is an option, it only funds a small

TLDR: Avanz Capital Egypt and Avanz Manara for Private Equity have invested in Bosta, a technology-based shipping and logistics company for e-commerce businesses in Egypt. Bosta, founded in 2017, has delivered over

TLDR: South Korean trading company SK Networks has partnered with venture capital firm Bow Capital, based in Silicon Valley, for investment cooperation. South Korean company SK Networks will sell its treasury stocks

TLDR: Speedinvest, a pan-European early-stage venture capital fund, has closed its fourth flagship fund, Speedinvest 4, at €350 million, surpassing its original goal of €300 million by €50 million. The new capital

TLDR: – Cornerstone Venture Partners Fund, a tech-focused venture capital firm, has launched its second VC fund with a focus on software-as-a-service (SaaS) platforms. – The firm has previously backed companies like

Venture capital firm Speedinvest has closed its latest fund at €350 million ($435 million), surpassing its target of €300 million. The final close brings the firm’s total assets under management to over

Venture capital funding in energy storage reached a record high in 2023, increasing by 59% year-over-year, according to a report by Mercom Capital. The report stated that smart grid companies received a

The global venture capital investment market size is expected to reach US$1,310.8 billion by 2032, exhibiting a growth rate of 17.9% during the forecast period. The key driver of this growth is

TLDR: VC firm AirTree Ventures has appointed Kell Reilly as a new partner. Reilly, a former managing director at private equity firm General Atlantic, will use his knowledge of California’s tech scene

CE-Ventures, the corporate venture capital platform of Crescent Enterprises, has invested in Freya Biosciences’ $38 million Series A funding round. The trans-Atlantic biotech company focuses on women’s health, particularly microbial immunotherapies. The